Stay updated with breaking news from Greg Lopes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An industry organization representing powerful drug middlemen said that banning an industry practice would lead to "higher costs and fewer choices for America’s employers." But to support it, the organization points to analysis that didn't look at private insurance and didn't reach the conclusion that it claimed.
The panel is expected to rule in the coming months, but the U.S. Supreme Court will have the final say.
The Pharmaceutical Care Management Association has sharply increased its federal lobbying spending to oppose legislation that would require pharmacy benefit managers to be more transparent in their business practices.
Despite a scarcity, several independent American pharmacies have ignored Ozempic shortages. (Photo : JOEL SAGET/AFP via Getty Images)This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication "Ozempic" (semaglutide) made by Danish pharmaceutical company "Novo Nordisk".
Two large health plans for public sector workers expect $28.5 million in savings over two years through a new contract with a pharmaceutical benefits manager.